Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Anbio Biotechnology's price to sales ratio was 20.5× on Nov 11, 2026, against 121.1× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 20.5× | −134.9 |
| 2025 | Dec 31, 2025 | 155.4× | – |
See a number that looks wrong?